Article
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
Cardiovascular drugs and therapy - 1 Apr 2009
Brugts J J, de Maat M P M, Boersma E, Witteman J C M, van Duijn C, Uitterlinden A G, Bertrand M, Remme W, Fox K, Ferrari R, Danser A H J, Simoons M L
Abstract excerpt
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors reduce clinical symptoms and improve outcome in patients with hypertension, heart failure, and stable coronary artery disease (CAD) and are among the most frequently used drugs in these patient groups. For hypertension, treatment is guide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.